Thailand to extend dose gap for AstraZeneca vaccine to 16 weeks


  • World
  • Monday, 24 May 2021

FILE PHOTO: A medical worker holds a bottle of AstraZeneca's COVID-19 vaccine at a vaccination centre in Kuala Lumpur, Malaysia May 5, 2021. REUTERS/Lim Huey Teng/File Photo

BANGKOK (Reuters) - Thailand will extend the gap between the first and second doses of AstraZeneca's COVID-19 vaccine to 16 weeks, in an effort to inoculate more people faster, a senior health official said on Monday.

The plan follows a similar decision by Spain to stretch the gap between two AstraZeneca doses to 16 weeks, which is beyond the 12 weeks maximum interval approved by the European Medicines Agency. A 16-week interval has not been tested in human trials.

Get 30% off with our ads free Premium Plan

Monthly Plan

RM9.73/month

Annual Plan

RM8.63/month

Billed as RM103.60/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Nintendo sues company for piracy on ‘colossal scale’
Vietnam eyes crackdown on workers rights, foreign aid, report says
Some US lawmakers urge Biden, Blinken not to recognize new Pakistan government
Palestinians say Israeli troops fired at people seeking food
UK's Rwanda plan for asylum seekers could cost more than 600 million pounds
Former Canadian PM Mulroney, driver of US free trade deal, dies aged 84
Alexei Navalny to be buried in Moscow amid uncertainty, tight security
Bangladesh building fire kills at least 43, injures dozens
Roundup: U.S. Fed's closely watched inflation measure rises 2.4 pct in January
Canada's economic growth slows in 2023

Others Also Read